Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:01 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001213900-26-055769
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Related party accounts payable and other current liabilities | 2,995 | (5,205) |
| Net cash used in operating activities | (23,578) | (20,869) |
| Cash flows from investing activities: | ||
| Purchases of property and equipment | (73) | (13) |
| Purchases of marketable securities | (90,834) | (44,290) |
| Proceeds from maturities of marketable securities | 76,470 | 87,169 |
| Net cash (used in) provided by investing activities | (14,437) | 42,866 |
| Cash flows from financing activities: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Oruka Therapeutics, Inc.'s capex?
- Oruka Therapeutics, Inc. (ORKA) reported capex of $73K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s capex changed year-over-year?
- Oruka Therapeutics, Inc.'s capex increased by 461.5% year-over-year, from $13K to $73K.
- What is the long-term trend for Oruka Therapeutics, Inc.'s capex?
- Over 2 years (2021 to 2025), Oruka Therapeutics, Inc.'s capex has grown at a 120.5% compound annual growth rate (CAGR), from $43K to $209K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Oruka Therapeutics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude